PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

PET scans offer insight into how ketamine affects depression
Thanks to a newly developed radiotracer and PET imaging, experts believe they may have unearthed new insights on the drug's impact.
Combining PET and MRI data may be key to differentiating new type of dementia
Limbic-predominant age-related TDP-43 encephalopathy, also known as LATE, was recently recognized as a type of dementia that occurs in older adults. It typically presents as memory-related cognitive decline.
Side effect of popular Alzheimer's treatment may actually be a good sign, new PET findings suggest
Amyloid-related imaging abnormality edema is a known side effect of anti-amyloid monoclonal antibody treatments, such as Leqembi and donanemab Kisunla.
Drugmaker expands manufacturing of popular prostate PET imaging agent
The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.
FDA clears new PET/MRI combo system from Siemens Healthineers
The Biograph One is the company's second-generation PET/MRI combo scanner—its first in 14 years.

PET scans spot brain abnormalities in long COVID patients

For 47% of patients with long COVID symptoms, brain PET scans identified mild to moderate or severe hypometabolic patterns.

FDA approves new radioligand therapy for PSMA positive metastatic prostate cancer

In clinical trials, the therapy reduced patients' risk of death by 38%, along with significantly decreasing disease progression.

'Pandemic brain': PET/MRI images reveal how COVID's impact is felt by non-infected individuals

A new analysis in Brain, Behavior, and Immunity shows that no one is immune to the effects of the ongoing pandemic.

Prominent imaging society advocates for 5 changes following CMS amyloid PET payment decision

SNMMI is fighting for expanded coverage for amyloid PET, including broadening accepted sites of service, among other changes.

New advanced PET imaging reveals root of cognitive decline in patients with Alzheimer's

The scans unearthed a significant association between synaptic density and decreased cognitive performance, Yale researchers revealed recently.

Is PET/CT or multiparametric MRI best for detecting prostate cancer? New research offers guidance

A comparison of the detection rates for 68Ga-PSMA PET/CT and mpMRI in low, intermediate and high-risk prostate cancer was recently shared by experts in EJNMMI.

F-18 FDG PET/CT highly sensitive for diagnosing cause of fevers with unknown origin

Such scans determined the final diagnosis in 54% of patients and were more accurate than CRP and WBC levels for identifying fever origin, according to research published in Scientific Reports.

PSMA-PET validates commonly used system measuring risk of prostate cancer recurrence

"The accuracy of PSMA-PET is essential to improve stratification and potentially outcomes both in low-risk and high-risk settings,” a doctor involved in the study explained in the Journal of Nuclear Medicine.

PET/CT

PET scans offer insight into how ketamine affects depression

Combining PET and MRI data may be key to differentiating new type of dementia

Side effect of popular Alzheimer's treatment may actually be a good sign, new PET findings suggest

Drugmaker expands manufacturing of popular prostate PET imaging agent

FDA clears new PET/MRI combo system from Siemens Healthineers